Papillary thyroid cancer historical perspective: Difference between revisions
Jump to navigation
Jump to search
m Bot: Removing from Primary care |
|||
(6 intermediate revisions by 2 users not shown) | |||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Ammu}}; {{AJL}} | {{CMG}}; {{AE}} {{Ammu}}; {{AJL}} | ||
==Overview== | ==Overview== | ||
There is limited information about the historical perspective of papillary thyroid cancer. | |||
==Discovery== | ==Discovery== | ||
*The most evident sign of [[thyroid]] pathology is goiter, which used to be referred to bronchocoele. | *The most evident [[sign]] of [[thyroid]] [[pathology]] is [[goiter]], which used to be referred to [[bronchocoele]]. | ||
*In 1656, Thomas Wharton named the gland the “[[thyroid]],” referring to its shield-like shape. | *In 1656, Thomas Wharton named the [[gland]] the “[[thyroid]],” referring to its shield-like shape. | ||
*In 1811, Bernard Courtois discovered iodine and in 1813, W. Prout used iodine to treat [[thyroid]] goiter. | *In 1811, Bernard Courtois discovered iodine and in 1813, W. Prout used [[iodine]] to treat [[thyroid]] [[goiter]]. | ||
*In 1835, James Graves provided the primary description of exophthalmic goiter. | *In 1835, James Graves provided the primary description of [[exophthalmic]] [[goiter]]. | ||
*In 1833, Allan Burns and Gaspard Bayle distinguished thyroid cancer from goiter.<ref name="pmid978-8181930828">{{Greene F, Komorowski A. Clinical Approach To Well-Differentited Thyroid Cancers. Delhi, India: Byworld Books; 2012.}} </ref> | *In 1833, Allan Burns and Gaspard Bayle distinguished [[thyroid cancer]] from [[goiter]].<ref name="pmid978-8181930828">{{Greene F, Komorowski A. Clinical Approach To Well-Differentited Thyroid Cancers. Delhi, India: Byworld Books; 2012.}}</ref> | ||
*There is limited information about the historical perspective of papillary thyroid cancer. | |||
===Landmark Events in the Development of Treatment Strategies=== | ===Landmark Events in the Development of Treatment Strategies=== | ||
*In the 19th century, [[thyroid]] surgery became an increasingly standard practice with the help of [[anesthesia]] and [[antiseptics]]. <ref name="ashjdSJHBDAJH">McCONAHEY W, HAY I, WOOLNER L, van HEERDEN J, TAYLOR W. Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome. Mayo Clinic Proceedings. 1986;61(12):978-996. doi:10.1016/s0025-6196(12)62641-x.</ref> | |||
*In 1880, Ludwig Rehn preformed the first total [[thyroidectomy]]. | *In 1880, Ludwig Rehn preformed the first total [[thyroidectomy]]. | ||
*In 1885, J. Mikulicz-Radecki preformed the first subtotal [[thyroidectomy]]. | *In 1885, J. Mikulicz-Radecki preformed the first subtotal [[thyroidectomy]]. | ||
*In 1934, Frederic and Irene Joliot-Curie discovered radioactive iodine isotope, which catalyzed diagnosis and treatment methods for [[thyroid]] diseases. | *In 1934, Frederic and Irene Joliot-Curie discovered [[radioactive iodine]] isotope, which catalyzed [[diagnosis]] and treatment methods for [[thyroid]] [[diseases]]. | ||
*In 1909, Theodor Kocher was awarded the Nobel Prize for his research on the [[physiology]] and [[hormonal]] implications of the [[thyroid]] [[gland]]. <ref name="pmid11297567">{{cite journal| author=Mazzaferri EL, Kloos RT| title=Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. | journal=J Clin Endocrinol Metab | year= 2001 | volume= 86 | issue= 4 | pages= 1447-63 | pmid=11297567 | doi=10.1210/jcem.86.4.7407 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11297567 }} </ref> | |||
==Reference== | |||
{{Reflist|2}} | |||
[[Category:Endocrine system]] | [[Category:Endocrine system]] | ||
Line 24: | Line 29: | ||
[[Category:Hereditary cancers]] | [[Category:Hereditary cancers]] | ||
[[Category:Thyroid disease]] | [[Category:Thyroid disease]] | ||
Latest revision as of 23:34, 29 July 2020
Papillary thyroid cancer Microchapters |
Differentiating Papillary thyroid cancer from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Papillary thyroid cancer historical perspective On the Web |
American Roentgen Ray Society Images of Papillary thyroid cancer historical perspective |
Risk calculators and risk factors for Papillary thyroid cancer historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]; Alison Leibowitz [3]
Overview
There is limited information about the historical perspective of papillary thyroid cancer.
Discovery
- The most evident sign of thyroid pathology is goiter, which used to be referred to bronchocoele.
- In 1656, Thomas Wharton named the gland the “thyroid,” referring to its shield-like shape.
- In 1811, Bernard Courtois discovered iodine and in 1813, W. Prout used iodine to treat thyroid goiter.
- In 1835, James Graves provided the primary description of exophthalmic goiter.
- In 1833, Allan Burns and Gaspard Bayle distinguished thyroid cancer from goiter.[1]
- There is limited information about the historical perspective of papillary thyroid cancer.
Landmark Events in the Development of Treatment Strategies
- In the 19th century, thyroid surgery became an increasingly standard practice with the help of anesthesia and antiseptics. [2]
- In 1880, Ludwig Rehn preformed the first total thyroidectomy.
- In 1885, J. Mikulicz-Radecki preformed the first subtotal thyroidectomy.
- In 1934, Frederic and Irene Joliot-Curie discovered radioactive iodine isotope, which catalyzed diagnosis and treatment methods for thyroid diseases.
- In 1909, Theodor Kocher was awarded the Nobel Prize for his research on the physiology and hormonal implications of the thyroid gland. [3]
Reference
- ↑ Template:Greene F, Komorowski A. Clinical Approach To Well-Differentited Thyroid Cancers. Delhi, India: Byworld Books; 2012.
- ↑ McCONAHEY W, HAY I, WOOLNER L, van HEERDEN J, TAYLOR W. Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome. Mayo Clinic Proceedings. 1986;61(12):978-996. doi:10.1016/s0025-6196(12)62641-x.
- ↑ Mazzaferri EL, Kloos RT (2001). "Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer". J Clin Endocrinol Metab. 86 (4): 1447–63. doi:10.1210/jcem.86.4.7407. PMID 11297567.